Stay updated on NVG-111 in ROR1+ Malignancies Clinical Trial
Sign up to get notified when there's something new on the NVG-111 in ROR1+ Malignancies Clinical Trial page.

Latest updates to the NVG-111 in ROR1+ Malignancies Clinical Trial page
- Check4 days agoChange DetectedA site-wide government funding notice is now displayed, directing users to opm.gov for updates, and the page revision label has been updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check11 days agoChange DetectedThe page gained a Show glossary control, capitalization changes to Last Update Submitted that Met QC Criteria and No FEAR Act Data, and the revision header updated to v3.4.0, replacing the previous entries including Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision tag updated to v3.3.4; the previous revision v3.3.3 was removed.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded a status metadata block showing the last known status (Unknown) for the study, including sponsor NovalGen Ltd. and date 2022-09.SummaryDifference0.4%

- Check46 days agoChange DetectedFooter updated to Revision: v3.3.3; the HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry were removed.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed on the page; no visible changes to study details or other user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to NVG-111 in ROR1+ Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NVG-111 in ROR1+ Malignancies Clinical Trial page.